Low-density neutrophils and their role in COVID-19 complications
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19
This study is looking at how a type of white blood cell called low-density neutrophils affects inflammation and blood clotting in people with COVID-19, to help find better ways to treat those who are seriously ill.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-10925222 on NIH RePORTER |
What this research studies
This research investigates how low-density neutrophils contribute to inflammation and blood clotting issues in patients with COVID-19. By examining the immune response and the presence of these specific neutrophils in patients, the study aims to understand their correlation with disease severity and complications like acute respiratory distress syndrome (ARDS). The approach includes analyzing blood samples from COVID-19 patients to identify the levels of these neutrophils and associated inflammatory markers. This could lead to better therapeutic strategies for managing severe COVID-19 cases.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with COVID-19, especially those experiencing severe symptoms or complications like ARDS.
Not a fit: Patients with mild COVID-19 symptoms or those who have fully recovered from the virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for COVID-19 patients, particularly those at risk of severe complications.
How similar studies have performed: Other research has shown promising results in understanding the immune response in COVID-19, making this approach both relevant and potentially impactful.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Yan, Jun — University of Louisville
- Study coordinator: Yan, Jun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.